BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026

  April 3, 2026

   · 

  6 min read
• Press Releases

  Minerva Announces Leadership Transition

  April 3, 2026

   · 

  5 min read
• Press Releases

  Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 2, 2026

  April 3, 2026

   · 

  2 min read
• Press Releases

  Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - April 2, 2026

  April 3, 2026

   · 

  1 min read
• Press Releases

  Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 2, 2026

  April 3, 2026

   · 

  1 min read
• Press Releases

  FibroBiologics Announces Closing of $3 Million Public Offering

  April 3, 2026

   · 

  4 min read
• Press Releases

  Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 2, 2026

  April 3, 2026

   · 

  1 min read
• Press Releases

  Hoth Therapeutics Announces Closing of $2.0 Million Registered Direct Offering

  April 3, 2026

   · 

  6 min read
• Press Releases

  Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 2, 2026

  April 3, 2026

   · 

  1 min read
• Press Releases

  Vedanta Biosciences Announces the Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection Will Continue as Planned Following Protocol-Specified Interim Analysis

  April 3, 2026

   · 

  4 min read